Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |